Skip to main content

Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis.

Publication ,  Journal Article
Bauer, ME; Price, LK; MacEachern, MP; Housey, M; Langen, ES; Bauer, ST
Published in: J Obstet Gynaecol
February 2018

Although it is known that corticosteroid administration causes leukocytosis, the magnitude and length of time this leukocytosis persists is unknown during pregnancy. This study aimed to establish the expected range of maternal leukocytosis in healthy pregnant women at risk for preterm delivery after antenatal corticosteroid administration. PubMed, Embase and ClinicalTrials.gov were searched to identify the studies in healthy women at risk for preterm delivery without signs of clinical infection that reported white blood cell values preceding and after antenatal corticosteroid administration. The inverse variance weighting technique was used to calculate the weighted means and the standard deviation from the mean for each time period. Six studies met inclusion criteria and included 524 patients and 1406 observations. Mean ± standard deviation maternal white blood cell count values prior to antenatal corticosteroid administration and up to 24, 48, 72 and 96 hours after corticosteroid administration were 10.4 ± 2.4, 13.6 ± 3.6, 12.1 ± 3.0, 11.5 ± 2.9 and 11.1 ± 2.5 × 109/L, respectively. Leukocytosis in healthy, non-infected women is expected to peak 24 hours after antenatal corticosteroid administration and the magnitude of increase is small. Impact statement What is already known on this subject: While it is well known that administration of antenatal corticosteroids causes leukocytosis, it is currently unknown the magnitude and length of time the leukocytosis persists. What the results of this study add: This study establishes the expected range and the temporal progression and regression with antenatal corticosteroid administration in healthy pregnant women at risk for preterm delivery without clinical signs of infection. What the implications are of these findings for clinical practice and/or further research: Clinicians may wish to consider further investigation into the clinical cause, whether infectious or non-infectious, for absolute values and changes outside this range.

Duke Scholars

Published In

J Obstet Gynaecol

DOI

EISSN

1364-6893

Publication Date

February 2018

Volume

38

Issue

2

Start / End Page

210 / 216

Location

England

Related Subject Headings

  • Time Factors
  • Risk Factors
  • Premature Birth
  • Pregnancy Complications, Hematologic
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Obstetric Labor, Premature
  • Leukocytosis
  • Leukocyte Count
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bauer, M. E., Price, L. K., MacEachern, M. P., Housey, M., Langen, E. S., & Bauer, S. T. (2018). Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis. J Obstet Gynaecol, 38(2), 210–216. https://doi.org/10.1080/01443615.2017.1342614
Bauer, Melissa E., Laura K. Price, Mark P. MacEachern, Michelle Housey, Elizabeth S. Langen, and Samuel T. Bauer. “Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis.J Obstet Gynaecol 38, no. 2 (February 2018): 210–16. https://doi.org/10.1080/01443615.2017.1342614.
Bauer ME, Price LK, MacEachern MP, Housey M, Langen ES, Bauer ST. Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis. J Obstet Gynaecol. 2018 Feb;38(2):210–6.
Bauer, Melissa E., et al. “Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis.J Obstet Gynaecol, vol. 38, no. 2, Feb. 2018, pp. 210–16. Pubmed, doi:10.1080/01443615.2017.1342614.
Bauer ME, Price LK, MacEachern MP, Housey M, Langen ES, Bauer ST. Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis. J Obstet Gynaecol. 2018 Feb;38(2):210–216.

Published In

J Obstet Gynaecol

DOI

EISSN

1364-6893

Publication Date

February 2018

Volume

38

Issue

2

Start / End Page

210 / 216

Location

England

Related Subject Headings

  • Time Factors
  • Risk Factors
  • Premature Birth
  • Pregnancy Complications, Hematologic
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Obstetric Labor, Premature
  • Leukocytosis
  • Leukocyte Count
  • Humans